$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

$efsi Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000088064116000173 Filed on August 15, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$6.642M	$6.121M
YoY Change	8.51%	-4.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$290.0K	$290.0K
YoY Change	0.0%	20.83%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$297.0K	$327.0K
YoY Change	-9.17%	-32.99%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.251M	$1.007M
YoY Change	123.54%	-63.84%
Income Tax	$641.0K	$209.0K
% Of Pretax Income	28.48%	20.75%
Net Earnings	$1.610M	$798.0K
YoY Change	101.75%	-59.24%
Net Earnings / Revenue	24.24%	13.04%
Basic Earnings Per Share	$0.46	$0.23
Diluted Earnings Per Share	$0.46	$0.23
COMMON SHARES
Basic Shares Outstanding	3.540M shares	3.487M shares
Diluted Shares Outstanding	3.540M shares	3.487M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$29.59M	$12.15M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$20.50M	$20.81M
YoY Change	-1.49%	21.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$677.4M	$634.3M
YoY Change	6.79%	5.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$8.300M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$8.300M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$7.200M
YoY Change	-100.0%	0.0%
Other Long-Term Liabilities	$4.800M	$2.000M
YoY Change	140.0%	-13.04%
Total Long-Term Liabilities	$4.800M	$9.200M
YoY Change	-47.83%	-3.16%
TOTAL LIABILITIES
Total Short-Term Liabilities		$8.300M
Total Long-Term Liabilities	$4.800M	$9.200M
Total Liabilities	$596.0M	$560.4M
YoY Change	6.36%	5.43%
SHAREHOLDERS EQUITY
Retained Earnings	$56.41M	$51.44M
YoY Change	9.65%	6.93%
Common Stock	$8.817M	$8.681M
YoY Change	1.57%	1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$81.40M	$73.94M
YoY Change
Total Liabilities & Shareholders Equity	$677.4M	$634.3M
YoY Change	6.79%	5.41%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	$1.610M	$798.0K
YoY Change	101.75%	-59.24%
Depreciation, Depletion And Amortization	$290.0K	$290.0K
YoY Change	0.0%	20.83%
Cash From Operating Activities	$1.210M	$460.0K
YoY Change	163.04%	-62.6%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$940.0K
YoY Change	-90.43%	347.62%
Acquisitions
YoY Change
Other Investing Activities	-$8.230M	-$34.67M
YoY Change	-76.26%	1033.01%
Cash From Investing Activities	-$8.320M	-$35.61M
YoY Change	-76.64%	988.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.25M	20.92M
YoY Change	-46.22%	421.7%
NET CHANGE
Cash From Operating Activities	1.210M	460.0K
Cash From Investing Activities	-8.320M	-35.61M
Cash From Financing Activities	11.25M	20.92M
Net Change In Cash	4.140M	-14.23M
YoY Change	-129.09%	-822.34%
FREE CASH FLOW
Cash From Operating Activities	$1.210M	$460.0K
Capital Expenditures	-$90.00K	-$940.0K
Free Cash Flow	$1.300M	$1.400M
YoY Change	-7.14%	-2.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000880641
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3548574	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	EAGLE FINANCIAL SERVICES INC
	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	110000	USD
	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	86000	USD
CY2015Q2	efsi	Atm Network Fees AtmNetworkFees	191000	USD
	efsi	Atm Network Fees AtmNetworkFees	349000	USD
CY2016Q2	efsi	Atm Network Fees AtmNetworkFees	259000	USD
	efsi	Atm Network Fees AtmNetworkFees	436000	USD
CY2015Q2	efsi	Bank Franchise Tax BankFranchiseTax	126000	USD
	efsi	Bank Franchise Tax BankFranchiseTax	243000	USD
CY2016Q2	efsi	Bank Franchise Tax BankFranchiseTax	125000	USD
	efsi	Bank Franchise Tax BankFranchiseTax	251000	USD
	efsi	Change In Market Value Of Interest Rate Swap Non Cash ChangeInMarketValueOfInterestRateSwapNonCash	53000	USD
	efsi	Change In Market Value Of Interest Rate Swap Non Cash ChangeInMarketValueOfInterestRateSwapNonCash	0	USD
CY2016Q2	efsi	Consolidated Financial Ownership Wholly Owned Subsidiary Percentage ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage	1.00
CY2015Q2	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	520000	USD
	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	520000	USD
CY2016Q2	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	0	USD
	efsi	Costtoterminateoperatinglease Costtoterminateoperatinglease	0	USD
CY2015Q4	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	2
CY2016Q2	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	3
CY2015Q4	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	500000	USD
CY2016Q2	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	1217000	USD
	efsi	Increase Decrease In Federal Home Loan Bank Advances Net IncreaseDecreaseInFederalHomeLoanBankAdvancesNet	20000000	USD
	efsi	Increase Decrease In Federal Home Loan Bank Advances Net IncreaseDecreaseInFederalHomeLoanBankAdvancesNet	0	USD
CY2015Q2	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	45000	USD
	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	91000	USD
CY2016Q2	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	39000	USD
	efsi	Interest On Interest Rate Swap InterestOnInterestRateSwap	80000	USD
	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	20000	USD
	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	16000	USD
	efsi	Number Of Retired Employees Provided Health Care And Life Insurance NumberOfRetiredEmployeesProvidedHealthCareAndLifeInsurance	9
CY2015Q2	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	-510000	USD
	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	-299000	USD
CY2016Q2	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	222000	USD
	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	511000	USD
CY2015Q4	efsi	Other Real Estate Gross OtherRealEstateGross	806000	USD
CY2016Q2	efsi	Other Real Estate Gross OtherRealEstateGross	806000	USD
CY2015Q2	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	14000	USD
	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	20000	USD
CY2016Q2	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	2000	USD
	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	2000	USD
	efsi	Period Past Due Loan Considered Payment Default PeriodPastDueLoanConsideredPaymentDefault	P30D
	efsi	Post Retirement Benefits Age Eligibility Requirement PostRetirementBenefitsAgeEligibilityRequirement	P65Y
	efsi	Post Retirement Benefits Service Eligibility Requirement PostRetirementBenefitsServiceEligibilityRequirement	P15Y
CY2015Q4	efsi	Time Deposits250000or More TimeDeposits250000orMore	11927000	USD
CY2016Q2	efsi	Time Deposits250000or More TimeDeposits250000orMore	20326000	USD
CY2015Q4	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	80444000	USD
CY2016Q2	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	68807000	USD
CY2015Q2	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	1
	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	1
CY2016Q2	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	0
	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	2
	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	2
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-104000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-115000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1315000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1723000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	734000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1051000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1614000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2044000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13730000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14129000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	132000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	107000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	5000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2015Q4	us-gaap	Assets Assets	653272000	USD
CY2016Q2	us-gaap	Assets Assets	677388000	USD
CY2015Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	105823000	USD
CY2016Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	102782000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	105823000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	102782000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1937000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3039000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	402000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	104288000	USD
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	99743000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	43000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	402000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	46860000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	359000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	43273000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	3587000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	96000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	86000	USD
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	45
CY2016Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	0
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34564000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12145000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23221000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29594000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-22419000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6373000	USD
CY2015Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	11082000	USD
CY2016Q2	us-gaap	Cash And Due From Banks CashAndDueFromBanks	9473000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	23221000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	29594000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3517648	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3546802	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8758000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	8817000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-191000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1672000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2040000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4128000	USD
CY2015Q4	us-gaap	Deposits Domestic DepositsDomestic	550718000	USD
CY2016Q2	us-gaap	Deposits Domestic DepositsDomestic	571229000	USD
	us-gaap	Depreciation Depreciation	398000	USD
	us-gaap	Depreciation Depreciation	464000	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	0	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	71000	USD
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2015Q2	us-gaap	Equipment Expense EquipmentExpense	260000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	1686000	USD
CY2016Q2	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	992000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	1821000	USD
CY2014Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5080000	USD
CY2015Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5536000	USD
CY2015Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	23000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	34000	USD
CY2016Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	0	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	0	USD
CY2015Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	26000	USD
	us-gaap	Dividend Income Operating DividendIncomeOperating	33000	USD
CY2016Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	23000	USD
	us-gaap	Dividend Income Operating DividendIncomeOperating	46000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	1392000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	1412000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
	us-gaap	Equipment Expense EquipmentExpense	406000	USD
CY2016Q2	us-gaap	Equipment Expense EquipmentExpense	355000	USD
	us-gaap	Equipment Expense EquipmentExpense	665000	USD
CY2015Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	103000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	211000	USD
CY2016Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	99000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	204000	USD
CY2015Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	20000000	USD
CY2016Q2	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	20000000	USD
CY2015Q2	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	307000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	597000	USD
CY2016Q2	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	290000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	580000	USD
CY2015Q2	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	356000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	784000	USD
CY2016Q2	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	380000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	708000	USD
CY2015Q2	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	930000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4959000	USD
CY2016Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4973000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	4383000	USD
CY2016Q2	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	4443000	USD
CY2015Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	576000	USD
CY2016Q2	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	530000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	343000	USD
CY2015	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	562000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	90000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	320000	USD
CY2015	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	456000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	155000	USD
CY2015Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	481570000	USD
CY2016Q2	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	505298000	USD
CY2015Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	14003000	USD
CY2016Q2	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	12109000	USD
CY2015	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	24
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	25
CY2015Q2	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	523000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	523000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	832000	USD
CY2015Q2	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	519000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	519000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	832000	USD
CY2015Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7500000	USD
CY2016Q2	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7800000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	307000	USD
CY2016Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	33000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	489679000	USD
CY2016Q2	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	505991000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5285000	USD
CY2016Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3978000	USD
CY2015Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	5894000	USD
CY2016Q2	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	11416000	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-1000	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2015Q2	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	22000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	96000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	0	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	86000	USD
CY2015Q2	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-73000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-92000	USD
CY2016Q2	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-47000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-47000	USD
CY2015	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	14350000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	12209000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	12313000	USD
CY2015	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	404000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	111000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	201000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	14026000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	12137000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	576000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	530000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	14999000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	12949000	USD
CY2015	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	8571000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	6740000	USD
CY2015	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	183000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	95000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	8334000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	6602000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	8960000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	7053000	USD
CY2015	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	5779000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	5573000	USD
CY2015	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	221000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	106000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	5692000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	5535000	USD
CY2015Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	6039000	USD
CY2016Q2	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	5896000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1007000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2986000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2251000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4367000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	209000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	733000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	641000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1232000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	583000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	20286000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	23749000	USD
	us-gaap	Increase Decrease In Federal Funds Purchased IncreaseDecreaseInFederalFundsPurchased	-8329000	USD
	us-gaap	Increase Decrease In Federal Funds Purchased IncreaseDecreaseInFederalFundsPurchased	0	USD
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-574000	USD
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	502000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1306000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-60000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-1315000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-3238000	USD
CY2015Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	192000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	413000	USD
CY2016Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	131000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	267000	USD
CY2015Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6121000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12059000	USD
CY2016Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6642000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13063000	USD
CY2015Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5437000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10738000	USD
CY2016Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5883000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	11592000	USD
CY2015Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	272214000	USD
CY2016Q2	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	284572000	USD
CY2015Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	12139000	USD
CY2016Q2	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	20121000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	105560000	USD
CY2016Q2	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	113152000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	86199000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	366000	USD
CY2016Q2	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	86741000	USD
CY2015Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	80455000	USD
CY2016Q2	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	84679000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	327000	USD
	us-gaap	Interest Expense InterestExpense	724000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	297000	USD
	us-gaap	Interest Expense InterestExpense	604000	USD
CY2015Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	66000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	200000	USD
CY2016Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	64000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	129000	USD
CY2015Q2	us-gaap	Interest Expense Deposits InterestExpenseDeposits	182000	USD
CY2016Q2	us-gaap	Interest Expense Deposits InterestExpenseDeposits	194000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	395000	USD
CY2015Q2	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	1000	USD
	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	1000	USD
CY2016Q2	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	0	USD
	us-gaap	Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2015Q2	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	33000	USD
	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	66000	USD
CY2016Q2	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	0	USD
	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	0	USD
CY2015Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	6000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	17000	USD
CY2016Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	22000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	38000	USD
CY2015Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	5494000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10902000	USD
CY2016Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6345000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12380000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5794000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11335000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6345000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12459000	USD
CY2015Q2	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	246000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	489000	USD
CY2016Q2	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	232000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	465000	USD
CY2015Q2	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	406000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	782000	USD
CY2016Q2	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	482000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	922000	USD
	us-gaap	Interest Paid InterestPaid	812000	USD
	us-gaap	Interest Paid InterestPaid	612000	USD
CY2015Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3112000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6107000	USD
CY2016Q2	us-gaap	Noninterest Income NoninterestIncome	1738000	USD
	us-gaap	Noninterest Income NoninterestIncome	3373000	USD
CY2016Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3313000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6577000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	575051000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	595993000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	653272000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	677388000	USD
CY2015Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	149000	USD
CY2016Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	78000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4959000	USD
CY2016Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4973000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	495573000	USD
CY2016Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	517407000	USD
CY2015Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	490614000	USD
CY2016Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	512434000	USD
CY2015Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	184000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	303000	USD
CY2016Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	185000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	347000	USD
CY2015Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	0	USD
CY2016Q2	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	185000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6302000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19450000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30263000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17515000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1542000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4438000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2253000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	1610000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3135000	USD
CY2015Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	186133000	USD
CY2016Q2	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	197524000	USD
CY2015Q2	us-gaap	Noninterest Expense NoninterestExpense	6131000	USD
	us-gaap	Noninterest Expense NoninterestExpense	11189000	USD
CY2016Q2	us-gaap	Noninterest Expense NoninterestExpense	5832000	USD
	us-gaap	Noninterest Expense NoninterestExpense	11386000	USD
CY2015Q2	us-gaap	Noninterest Income NoninterestIncome	1644000	USD
	us-gaap	Noninterest Income NoninterestIncome	3273000	USD
CY2015Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	29000	USD
	us-gaap	Noninterest Income Other NoninterestIncomeOther	110000	USD
CY2016Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	76000	USD
	us-gaap	Noninterest Income Other NoninterestIncomeOther	178000	USD
CY2015Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	482043000	USD
CY2016Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	504046000	USD
CY2015Q2	us-gaap	Occupancy Net OccupancyNet	436000	USD
	us-gaap	Occupancy Net OccupancyNet	782000	USD
CY2016Q2	us-gaap	Occupancy Net OccupancyNet	367000	USD
	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-47000	USD
	us-gaap	Occupancy Net OccupancyNet	775000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	10183000	USD
CY2016Q2	us-gaap	Other Assets OtherAssets	9641000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-1477000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-784000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	652000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	1590000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	12000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	18000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-989000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-581000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	430000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	993000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	7000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	33000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	29000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1012000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-615000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	430000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	993000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-523000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-317000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	222000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	511000	USD
CY2015Q4	us-gaap	Other Liabilities OtherLiabilities	4333000	USD
CY2016Q2	us-gaap	Other Liabilities OtherLiabilities	4764000	USD
CY2015Q2	us-gaap	Other Noninterest Expense OtherNoninterestExpense	598000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1128000	USD
CY2016Q2	us-gaap	Other Noninterest Expense OtherNoninterestExpense	617000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1205000	USD
CY2014Q4	us-gaap	Other Real Estate OtherRealEstate	2102000	USD
CY2015Q2	us-gaap	Other Real Estate OtherRealEstate	2261000	USD
CY2015Q4	us-gaap	Other Real Estate OtherRealEstate	571000	USD
CY2016Q2	us-gaap	Other Real Estate OtherRealEstate	524000	USD
	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	561000	USD
CY2015	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	867000	USD
	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	0	USD
	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	402000	USD
CY2015	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	2110000	USD
	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	0	USD
	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0	USD
CY2015	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-288000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	16749000	USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	21905000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1018000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1077000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	19966000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	12391000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2188000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105000	USD
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	38000	USD
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	22000	USD
CY2016Q2	us-gaap	Pledged Financial Instruments Not Separately Reported Securities Pledged PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged	2900000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5131000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	12593000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2324000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	4314000	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	8000	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	1000	USD
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	310000	USD
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	900000	USD
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	0	USD
CY2015Q2	us-gaap	Professional Fees ProfessionalFees	261000	USD
	us-gaap	Professional Fees ProfessionalFees	503000	USD
CY2016Q2	us-gaap	Professional Fees ProfessionalFees	281000	USD
	us-gaap	Professional Fees ProfessionalFees	509000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20964000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20495000	USD
CY2015Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	300000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	433000	USD
CY2016Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	79000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	433000	USD
CY2015	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-227000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	79000	USD
CY2015Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	571000	USD
CY2016Q2	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	524000	USD
CY2015Q4	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	235000	USD
CY2016Q2	us-gaap	Real Estate Owned Valuation Allowance RealEstateOwnedValuationAllowance	282000	USD
CY2015Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	22000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	96000	USD
CY2016Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	0	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	86000	USD
CY2015Q4	us-gaap	Restricted Investments RestrictedInvestments	1896000	USD
CY2016Q2	us-gaap	Restricted Investments RestrictedInvestments	1918000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	54682000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	56405000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	132000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	107000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	23.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	14650	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	14650	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.07
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	15151	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	23551	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14401	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	19901	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	22.27
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.61
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	22.98
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6250	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	8196	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	20.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	22.86
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	500000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	954	shares
	us-gaap	Stock Issued1 StockIssued1	374000	USD
	us-gaap	Stock Issued1 StockIssued1	335000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	16610	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	14810	shares
	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	875	shares
	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	648	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	6250	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	8196	shares
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	374000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	335000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	20000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	16000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	73132000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	73943000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	78221000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	81395000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-932000	USD
CY2015Q2	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	61000	USD
	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	112000	USD
CY2016Q2	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	51000	USD
	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	101000	USD
CY2015Q4	us-gaap	Time Deposits TimeDeposits	92371000	USD
CY2016Q2	us-gaap	Time Deposits TimeDeposits	89133000	USD
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	564000	USD
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	6000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1504000	USD
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3487215	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3482259	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3539876	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3535505	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3487215	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3482259	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3539876	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3535505	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 13. Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. This update is intended to provide guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Management is required under the new guidance to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the financial statements are issued when preparing financial statements for each interim and annual reporting period. If conditions or events are identified, the ASU specifies the process that must be followed by management and also clarifies the timing and content of going concern footnote disclosures in order to reduce diversity in practice. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2016. Early adoption is permitted. The Company does not expect the adoption of ASU 2014-15 to have a material impact on its consolidated financial statements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendments in ASU 2016-01, among other things: 1) Requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. 2) Requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. 3) Requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables). 4) Eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The amendments in this ASU are effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently assessing the impact that ASU 2016-01 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” Among other things, in the amendments in ASU 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (1) A lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and (2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted upon issuance. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. The Company is currently assessing the impact that ASU 2016-02 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During March 2016, the FASB issued ASU No. 2016-05, “Derivatives and Hedging (Topic 815): Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships.” The amendments in this ASU clarify that a change in the counterparty to a derivative instrument that has been designated as the hedging instrument does not, in and of itself, require dedesignation of that hedging relationship provided that all other hedge accounting criteria remain intact. The amendments are effective for public business entities for financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company does not expect the adoption of ASU 2016-05 to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-07, “Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting.” The amendments in this ASU eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, no retroactive adjustment of the investment is required. In addition, the amendments in this ASU require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method. Early adoption is permitted. The Company does not expect the adoption of ASU 2016-07 to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” The amendments in this ASU simplify several aspects of the accounting for share-based payment award transactions including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. The amendments are effective for public companies for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company is currently assessing the impact that ASU 2016-09 will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this ASU are effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently assessing the impact that ASU 2016-13 will have on its consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0000880641-16-000173-index-headers.html	Edgar Link	pending
0000880641-16-000173-index.html	Edgar Link	pending
0000880641-16-000173.txt	Edgar Link	pending
0000880641-16-000173-xbrl.zip	Edgar Link	pending
efsi-20160630.xml	Edgar Link	completed
efsi-20160630.xsd	Edgar Link	pending
efsi-20160630exhibit311.htm	Edgar Link	pending
efsi-20160630exhibit312.htm	Edgar Link	pending
efsi-20160630exhibit321.htm	Edgar Link	pending
efsi-20160630x10q.htm	Edgar Link	pending
efsi-20160630_cal.xml	Edgar Link	unprocessable
efsi-20160630_def.xml	Edgar Link	unprocessable
efsi-20160630_lab.xml	Edgar Link	unprocessable
efsi-20160630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

2016 Q2 Form 10-Q Financial Statement

#000088064116000173 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI EAGLE FINANCIAL SERVICES INC Stock $efsi

2016 Q2 Form 10-Q Financial Statement

#000088064116000173 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi